Company Name : Alexandria Pharmaceuticals ISIN Code : EGS38341C011 Reuters Code : AXPH.CA Content : Referring to the announcement published on the trading screens on 09/01/2024, concerning the Disclosure Form for the BoD & the shareholders' structure for the period ended 31/12/2023, according to Article 30 of the Listing Rules, a correction was received from the company. The Disclosure Form (1,143 KB) The Disclosure Form (1,143 KB)